Quality requirements of human use experience research on traditional Chinese medicine.
10.19540/j.cnki.cjcmm.20230601.501
- Author:
Ya-Qin TANG
1
;
Zhong-Qi YANG
1
;
Yan LING
1
;
Yan-Ping DU
1
;
Hui-Min TANG
1
;
Shi-Hao NI
1
;
Lu LU
1
Author Information
1. the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510405, China.
- Publication Type:Journal Article
- Keywords:
human use experience;
quality control;
research;
traditional Chinese medicine
- MeSH:
Humans;
Medicine, Chinese Traditional;
Prospective Studies;
Reproducibility of Results;
Retrospective Studies;
Pharmaceutical Preparations;
Drugs, Chinese Herbal/therapeutic use*
- From:
China Journal of Chinese Materia Medica
2023;48(17):4825-4828
- CountryChina
- Language:Chinese
-
Abstract:
The human use experience of traditional Chinese medicine(TCM) is of great significance for the development of new traditional Chinese medicine. In 2023, the National Medical Products Administration(NMPA) issued the Special Regulations on Registration Management of Traditional Chinese Medicine, which explicitly encouraged the conduct of high-quality human use experience research on TCM clinical practice to obtain sufficient evidence for registration support. It also required that human use experience research should comply with relevant requirements and undergo registration verification. The quality of human use experience research on TCM directly determines the reliability of the evidence. This article discussed the quality requirements for human use experience research on TCM from the perspectives of basic requirements, organizational management, key pharmaceutical information, scientific research, risk management, ethical compliance, and study implementation and proposed differential treatment in quality requirements and registration verification focus based on different research purposes, stages, and types of studies. While ensuring the authenticity of data, retrospective studies should pay particular attention to the integrity of the data, and prospective studies should focus on the normativity of the data, which may affect the research conclusions. Human use experience research, as part of drug registration materials, falls within the scope of relevant regulatory oversight. Researchers should have a strong awareness of regulations to avoid serious quality issues. The standardized conduct of human use experience research on TCM requires joint efforts from regulatory authorities, applicants, research institutions, and researchers to establish a research quality management system based on the clinical characteristics of TCM.
